Amedeo's Top 20

Amedeo Smart

Independent Medical Education

09 January 2023

Multidisciplinary Journal Club

  1. Glans I, Sonestedt E, Nagga K, Gustavsson AM, et al.
    Association Between Dietary Habits in Midlife With Dementia Incidence Over a 20-Year Period.
    Neurology 2023;100:e28-e37.

  1. Daniel EA, Thiruvengadam K, Rajamanickam A, Chandrasekaran P, et al.
    QuantiFERON supernatant-based host biomarkers predicting progression to active tuberculosis disease among household contacts of tuberculosis patients.
    Clin Infect Dis 2022.

  2. Valvano M, Magistroni M, Cesaro N, Carlino G, et al.
    Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis 2022.

  3. Beason-Held LL, Kerley CI, Chaganti S, Moghekar A, et al.
    Health Conditions Associated with Alzheimer's Disease and Vascular Dementia.
    Ann Neurol 2022.

  4. Messina R, Sudre CH, Wei DY, Filippi M, et al.
    BIOMARKERS OF MIGRAINE AND CLUSTER HEADACHE: DIFFERENCES AND SIMILARITIES.
    Ann Neurol 2022.

  1. Choi WM, Cheuk-Fung Yip T, Lai-Hung Wong G, Kim WR, et al.
    Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: individual patient data meta-analysis.
    J Hepatol 2022.

  2. Dong T, Tashtish N, Walker J, Neeland I, et al.
    Coronary Artery Calcium Scoring for Risk Assessment in Patients With Severe Hypercholesterolemia.
    Am J Cardiol 2022;190:48-53.

  3. Hassing CMS, Mejdahl MK, Laenkholm AV, Kroman N, et al.
    Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.
    Breast Cancer Res Treat 2022.

  4. Lange M, Arbogast SL, Hardy-Leger I, Rigal O, et al.
    Cognitive change in breast cancer patients up to 2 years after diagnosis.
    J Natl Cancer Inst 2022.

  5. Wu HL, Luo ZY, He ZL, Gong Y, et al.
    All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.
    Br J Cancer 2022.

  1. Ehmann S, Shay K, Zhou Q, Iasonos A, et al.
    Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
    Gynecol Oncol 2022;169:118-124.

  2. Ma C, Panaccione R, Xiao Y, Khandelwal Y, et al.
    REMIT-UC: Real World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis.
    Am J Gastroenterol 2022.

  3. Poke G, Stanley J, Scheffer IE, Sadleir LG, et al.
    Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
    Neurology 2022.

  4. Labidi-Galy SI, Rodrigues M, Sandoval JL, Kurtz JE, et al.
    Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.
    Ann Oncol 2022.

  5. Zhang X, Liu JR, Mu ZZ, Cheng XQ, et al.
    Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-risk Papillary Thyroid Cancer.
    J Clin Endocrinol Metab 2022.

  1. Gwark S, Kim HJ, Kim J, Chung IY, et al.
    Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Ann Surg Oncol 2022.

  2. Block VJ, Cheng S, Juwono J, Cuneo R, et al.
    Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
    Mult Scler 2022.

  3. Katsanos AH, Sarraj A, Froehler M, Purrucker J, et al.
    Intravenous Thrombolysis Initiated Before Transfer for Endovascular Stroke Thrombectomy: A Systematic Review and Meta-analysis.
    Neurology 2022.

  4. Bishop EJ, Tiruvoipati R.
    Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    J Antimicrob Chemother 2022;78:21-30.

  5. Rajwa P, Pfister D, Rieger C, Heidenreich J, et al.
    Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer.
    Prostate 2022.


more..

Privacy Policy